Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wal-Mart’s Generic Rx Program Having “Immaterial” Impact On CVS

This article was originally published in The Pink Sheet Daily

Executive Summary

Caremark and MinuteClinic relationship could boost disease management offerings, CVS Exec says.

You may also be interested in...



CVS' Merger With Caremark Gives Pharmacy "Access To Payers"

A year in the making, the transaction could reshape the retail pharmacy landscape.

Wal-Mart Generic Rx Program Expansion Underway With Addition Of 12 More States

Retailer plans to continue expanding its $4 generic drug program to as many states as possible.

Novartis Institute For Tropical Diseases Could Have TB Drug In Clinic By Late 2007

Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS063401

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel